体外受精-胚胎移植周期中黄体酮补充启动时机对结局的影响:一项前瞻性随机对照试验
本研究为单中心前瞻性随机对照试验,纳入233例≤35岁、首次接受GnRH激动剂长方案IVF-ET的女性,随机分为取卵后1天开始黄体支持(A组117例)与取卵当日开始(B组116例)。两组临床妊娠率、种植率、早期流产率及活产率均无显著差异。
要点
- 取卵后1天启动黄体酮补充与取卵当日启动相比,临床妊娠率无显著差异。
- 两组种植率、早期流产率及活产率均相似,无显著差异。
- 研究提示取卵后1天启动黄体支持未降低临床妊娠率、种植率或活产率。
核心结论
- 取卵后1天启动黄体酮补充未降低GnRH激动剂长方案IVF-ET女性的临床妊娠率、种植率或活产率。
研究设计与样本
- 单中心前瞻性随机对照试验,纳入233例≤35岁、第3天FSH<15 mIU/mL、首次IVF-ET且采用GnRH激动剂长方案的患者。
- A组117例于取卵后1天开始黄体支持,B组116例于取卵当日开始黄体支持。
主要发现
- 临床妊娠率A组55.3% vs B组51.5%,两组相似。
- 种植率A组38.4% vs B组38.0%,两组相似。
- 早期流产率A组7.7% vs B组7.5%,两组相似。
- 活产率A组45.7% vs B组46.6%,两组无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the influence of the start point of luteal support on clinical pregnancy rate, implantation rate, and live birth rate of in vitro fertilization and embryo transfer (IVF-ET) cycles. DESIGN: Single-center prospective randomized controlled trial. SETTING: University-affiliated IVF unit. PATIENT(S): Women ≤35 years of age with day 3 FSH levels <15 mIU/mL, who were undergoing their first IVF-ET cycles and received ovarian stimulation with the use of a GnRH agonist long protocol. INTERVENTION(S): The patients were randomized on the day of hCG trigger to receive luteal phase support either 1 day after oocyte retrieval (group A) or on the day of oocyte retrieval (group B). MAIN OUTCOME MEASURE(S): Clinical pregnancy rate, implantation rate, miscarriage rate in the first trimester of pregnancy, and live birth rate per embryo transfer cycle. RESULT(S): Two hundred thirty-three patients were enrolled in this study: 117 were assigned to group A and 116 to group B. The clinical pregnancy rate (group A vs. group B: 55.3% vs. 51.5%), implantation rate (38.4% vs. 38.0%), and miscarriage rate (7.7% vs. 7.5%) were similar between the two groups. The live birth rate also did not significantly differ between the two groups (45.7% vs. 46.6%). CONCLUSION(S): Our study indicated that the initiation of progesterone supplementation 1 day after oocyte retrieval did not decrease the clinical pregnancy rate, implantation rate, or live birth rate in women undergoing IVF-ET cycles with the use of the GnRH agonist long protocol. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR-IPR-14005293.
引用
- Gao J, Gu F, Miao BY, et al. Effect of the initiation of progesterone supplementation in in vitro fertilization-embryo transfer outcomes: a prospective randomized controlled trial. Fertil Steril. 2017. PMID: 29175065. doi:10.1016/j.fertnstert.2017.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。